GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitae Corp (LTS:0JDB) » Definitions » Cyclically Adjusted Price-to-FCF

Invitae (LTS:0JDB) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Invitae Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Invitae Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Invitae's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitae Cyclically Adjusted Price-to-FCF Chart

Invitae Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Invitae Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Invitae's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Invitae's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitae's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitae's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Invitae's Cyclically Adjusted Price-to-FCF falls into.



Invitae Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Invitae's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Invitae's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.25/129.8595*129.8595
=-0.250

Current CPI (Sep. 2023) = 129.8595.

Invitae Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 -0.557 98.326 -0.736
201403 -0.609 99.695 -0.793
201406 -0.784 100.560 -1.012
201409 -0.674 100.428 -0.872
201412 -0.616 99.070 -0.807
201503 -1.131 99.621 -1.474
201506 -0.708 100.684 -0.913
201509 -0.733 100.392 -0.948
201512 -0.686 99.792 -0.893
201603 -0.783 100.470 -1.012
201606 -0.658 101.688 -0.840
201609 -0.625 101.861 -0.797
201612 -0.594 101.863 -0.757
201703 -0.552 102.862 -0.697
201706 -0.507 103.349 -0.637
201709 -0.530 104.136 -0.661
201712 -0.649 104.011 -0.810
201803 -0.639 105.290 -0.788
201806 -0.398 106.317 -0.486
201809 -0.274 106.507 -0.334
201812 -0.229 105.998 -0.281
201903 -0.392 107.251 -0.475
201906 -0.427 108.070 -0.513
201909 -0.433 108.329 -0.519
201912 -0.552 108.420 -0.661
202003 -0.664 108.902 -0.792
202006 -0.523 108.767 -0.624
202009 -0.493 109.815 -0.583
202012 -0.680 109.897 -0.804
202103 -0.495 111.754 -0.575
202106 -0.540 114.631 -0.612
202109 -0.826 115.734 -0.927
202112 -0.859 117.630 -0.948
202203 -0.737 121.301 -0.789
202206 -0.650 125.017 -0.675
202209 -0.589 125.227 -0.611
202212 -0.356 125.222 -0.369
202303 -0.143 127.348 -0.146
202306 -0.213 128.729 -0.215
202309 -0.250 129.860 -0.250

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Invitae  (LTS:0JDB) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Invitae Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Invitae's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitae (LTS:0JDB) Business Description

Traded in Other Exchanges
Address
1400 16th Street, San Francisco, CA, USA, 94103
Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.

Invitae (LTS:0JDB) Headlines

No Headlines